Dario Sabaghi

DLA Piper's move to King Abdullah Financial District is the latest sign that Riyadh's premier business address is becoming as attractive to lawyers as it is to bankers.

A new survey reveals nearly 10% of adults use cannabis for sleep, despite ongoing debate about its effectiveness. The National Sleep Foundation-funded study found cannabis users reported poorer sleep quality and shorter duration compared to non-users, suggesting a complex, bidirectional relationship where poor sleep might prompt cannabis use, or cannabis could worsen sleep. While many users believe it helps, scientific research remains mixed. THC can aid falling asleep but may reduce REM sleep, while CBD might alleviate anxiety to improve rest. Some studies show promise for specific conditions like insomnia, but overall, a consistent conclusion on cannabis's general sleep benefits is still lacking.

Analysis: Surviving the war and excluded from US talks, Iran's missile programme will remain central to its post-war deterrence doctrine

Gulf states have spent billions on sports over the years, but as Saudi Arabia shifts to a more selective investment strategy, law firms are rewriting their playbook.

German courts are clarifying a gray area in the 2024 cannabis reform regarding the legal status of cannabis cuttings. The Cannabis Act defined cuttings as propagation material but left ambiguous when they become regulated plants, affecting commercial sales. The Administrative Court of Cologne recently ruled that a cutting becomes a cannabis plant once planted in a growing medium, rejecting a retailer's request for commercial sale. The court clarified that the propagation material exemption is for private cultivation or associations, not a broad commercial market. This decision, consistent with a prior ruling, indicates a narrow judicial interpretation, classifying ready-to-grow cuttings as regulated cannabis plants. This provides a clearer framework for businesses and growers, despite significant public interest in commercial cutting sales.

Italy's surge in dealmaking lifted domestic firms into the LSEG's European top 25, while Clifford Chance dropped down the rankings.

Germany's medical cannabis market is seeing a shift towards cheaper, high-potency products following 2024 reforms that expanded access and simplified prescriptions. A new study reveals prices dropped significantly, while consumer demand gravitated towards cannabis with 20-29.9% THC. Researchers question if this trend, fueled by online dispensaries, truly serves medical needs or encourages recreational use, as high-potency products lack extensive proven benefits and pose risks.

The sale of e&'s stake in Vodafone to French billionaire Xavier Niel gave the law firms involved an opportunity to strengthen ties with longtime clients.

Lebanese citizens face a disastrous scenario in their search for justice after the June 26 signing of a new trilateral framework between the United States, Lebanon and Israel. With thousands of Lebanese killed and millions displaced, the agreement explicitly forces Beirut to cease its efforts to seek out accountability measures for Israel's crimes on its territory. That outcome cannot stand. Lebanese citizens deserve justice.

Curaleaf has become the first cannabis company to provide cannabis preparation under Spain’s new medical cannabis law.